Innate Pharma SA - SPONSORED ADS (IPHA)

Historical Holders from Q4 2019 to Q4 2025

Type / Class
Equity / SPONSORED ADS
Symbol
IPHA on Nasdaq
Price per share
$1.75
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
81,617
Holdings value
$157,932
% of all portfolios
0%
Share change
-18,221
Value change
-$33,200
Average buys %
0%
Average sells %
-0%
Number of holders
9
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, Innate Pharma SA - SPONSORED ADS (IPHA) has 9 institutional shareholders filing 13F forms. They hold 81,617 shares .

Institutional Holders of Innate Pharma SA - SPONSORED ADS (IPHA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 1,073 $1,878 -$2,114 $1.75 1
2025 Q3 81,617 $157,932 -$33,200 $1.93 9
2025 Q2 99,838 $179,124 -$103,610 $1.81 9
2025 Q1 158,189 $282,029 +$35,951 $1.78 10
2024 Q4 137,970 $255,200 -$185,233 $1.85 9
2024 Q3 237,742 $544,429 -$8,244 $2.29 7
2024 Q2 241,754 $469,203 -$47,223 $1.94 8
2024 Q1 253,918 $731,097 +$366,440 $2.88 9
2023 Q4 128,912 $360,800 -$534,506 $2.80 8
2023 Q3 318,407 $805,527 +$243,938 $2.53 8
2023 Q2 412 $1,000 -$171,049 $2.43 1
2023 Q1 396,953 $1,128,356 -$11,740 $2.85 8
2022 Q4 399,345 $1,489,515 -$839,353 $3.73 9
2022 Q3 779,329 $1,559,000 -$11,145 $2.00 8
2022 Q2 953,812 $2,575,000 -$72,850 $2.70 11
2022 Q1 952,242 $3,199,000 -$1,817,238 $3.36 12
2021 Q4 1,202,864 $5,489,000 +$1,081,290 $4.56 14
2021 Q3 943,114 $5,818,000 +$5,267,168 $6.17 18
2021 Q2 89,540 $296,000 -$324,284 $3.30 5
2021 Q1 176,028 $759,802 -$5,091,479 $4.32 7
2020 Q4 1,395,579 $5,707,000 -$1,116,727 $4.09 4
2020 Q3 1,683,925 $6,652,000 -$6,064,054 $3.90 6
2020 Q2 2,871,409 $20,310,000 -$29,641,435 $7.00 7
2020 Q1 7,339,905 $49,030,000 -$2,479,416 $6.68 9
2019 Q4 7,714,565 $49,665,000 +$49,665,212 $6.43 11